This solo episode of the Infectious Disease Podcast, hosted by Dr. Daniel Griffin, reviews recent significant literature across virology, bacteriology, mycology, and parasitology. The discussion begins with a meta-analysis supporting the two-dose initial influenza vaccination schedule for children, which significantly increases vaccine effectiveness. The podcast then delves into infective endocarditis, evaluating the new 2023 Duke criteria, which demonstrate higher sensitivity at the cost of much lower specificity, and presenting evidence that delaying antibiotics in stable patients until blood culture results are available is safe. Other topics include the CDC's updated 2025 guidelines for treating tularemia, risk factors for progression from Candida auris colonization to clinical infection, and a detailed look at the 2023 locally acquired malaria outbreaks in the United States. The episode concludes by questioning the routine treatment of fever in sepsis, presenting evidence that fever may be a beneficial adaptive response that improves antibiotic efficacy.
Infectious Disease Literature Review: October 2025
0:01:31 Influenza Vaccination in Children: A meta-analysis published in JAMA Network Open confirmed that for vaccine-naive children, a second dose of the influenza vaccine in their first season provides a significant boost in vaccine effectiveness. The effectiveness increased by 15 percentage points for children under nine and 28 percentage points for those under three. Takeaway: The data strongly validates the current WHO and AAP recommendations for a two-dose priming schedule for children receiving their first flu shot.
0:05:06 New Endocarditis Diagnostic Criteria: A study evaluates the updated 2023 ISCVID Duke criteria for diagnosing infective endocarditis (IE). While the new criteria have the highest sensitivity (71%) for detecting IE in patients with prosthetic materials, their specificity is very low (34%). Takeaway: The latest Duke criteria are better at identifying true cases but may lead to significant over-diagnosis of IE.
0:11:17 Timing of Antibiotics for Endocarditis: In hemodynamically stable patients with suspected IE, a study compared immediate antibiotic initiation versus delaying treatment until preliminary blood culture results were available. There was no difference in 30-day mortality (5% in both groups). Takeaway: It appears safe to wait for initial microbiology results before starting antibiotics in stable patients, which can help avoid unnecessary treatment and allow for more targeted therapy.
0:14:56 Updated CDC Tularemia Guidelines: The CDC released new 2025 recommendations for the treatment and prophylaxis of tularemia ("rabbit fever"), a rare disease caused by Francisella tularensis and a Tier 1 bioterrorism agent. The guidelines detail preferred treatments, such as doxycycline and fluoroquinolones. Takeaway: Clinicians have a new, comprehensive resource for managing this potentially serious infection.
0:18:27Candida auris Infection Risk: A study identified key risk factors for patients progressing from C. auris colonization to clinical infection. These include having five or more comorbidities, four or more invasive devices, or being fully dependent for care (eating, mobility). Takeaway: Patients with high medical complexity and dependency are at the greatest risk for developing invasive C. auris disease after colonization.
0:20:05 Locally Acquired Malaria in the US: The podcast reviews the public health response to the 10 locally acquired malaria cases in Florida, Texas, Maryland, and Arkansas in 2023βthe first such outbreaks in 20 years. Genetic analysis traced the P. vivax strains to Central/South America and the P. falciparum strain to Africa. Takeaway: Locally acquired malaria is a re-emerging threat in the US, highlighting the importance of robust public health surveillance and vector control.
0:24:34 The Role of Fever in Sepsis: A review article questions the routine practice of treating fever in septic patients. Evidence suggests that higher temperatures can improve antibiotic effectiveness (MICs) and that fever is an adaptive response. Takeaway: Automatically treating fever in sepsis might be counterproductive, and more research is needed to determine if this practice truly helps or harms patients.